dual CDK6/9 inhibitors (Anhui Chem-Bright Bioengineering)

N/A

Report date: 2025/01/26 18:09:26
NME

Base Information

Drug Namedual CDK6/9 inhibitors (Anhui Chem-Bright Bioengineering)
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionCyclin-dependent kinase 9 inhibitorsCyclin-dependent kinase 6 degraders
TargetsCyclin-dependent kinase 6Cyclin-dependent kinase 9
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesAnhui Chem Bright Bioengineering Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesAnhui Medical UniversityAnhui Chem Bright Bioengineering Co Ltd
Inactive CompaniesN/A
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A